The Senate Health, Education, Labor and Pensions Committee today held a hearing for Alex Azar, President Trump’s nominee for secretary of Health and Human Services. Azar, former president of Lilly USA and deputy HHS secretary under the George W. Bush administration, faced a number of questions from senators about his ties to the pharmaceutical industry and how he would tackle high drug prices. “I believe I can bring the skills and experiences to the table that can help us address these issues, while still encouraging discovery so Americans have access to high quality care,” Azar said. Trump nominated Azar for HHS secretary earlier this month. Tom Price, M.D., resigned as HHS secretary on Sept. 29. Deputy Secretary Eric Hargan has been serving as acting secretary. Azar will need to testify before the Senate Finance Committee, which has not announced a hearing date, before the full Senate votes on his appointment.

Related News Articles

Blog
Rick Pollack President and CEO, American Hospital Association Washington, DC COVID-19 has created the greatest financial crisis in history for hospitals and…
Blog
As I write, nearly 100,000 Americans have lost their lives to the COVID-19 pandemic. Much of the response to this crisis has fallen on America’s hospitals and…
Perspective
Over the past few weeks, we’ve been talking about the “triple whammy” of issues related to COVID-19 that are contributing to an unprecedented financial crisis…
Headline
The praise and support for our health care heroes is a wonderful thing and we must keep it up. At the same time, we must help our caregivers take care of…
Chairperson's File
The outpouring of love, support and gratitude shown toward our magnificent health care workers has helped to keep them going in the strenuous battle against…
Headline
The American Organization for Nursing Leadership yesterday unveiled a new resource to provide nurse leaders with practical tips and effective strategies for…